Literature DB >> 6407606

Cimetidine and metoclopramide in oesophageal reflux disease.

J G Temple, G V Bradby, F O O'Connor, K S Panesar, T O Mulligan, T J Robinson, D W Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6407606      PMCID： PMC1547777          DOI： 10.1136/bmj.286.6381.1863

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Effect of rising intragastric pH induced by several antacids on serum gastrin concentrations in duodenal ulcer patients and in a control group.

Authors:  G E Feurle
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

2.  Effect of metoclopramide on oesophageal peristalsis and gastro-oesophageal sphincter pressure. A study in normal subjects.

Authors:  L Wallin; S Boesby; T Madsen
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

3.  Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.

Authors:  J Behar; D L Brand; F C Brown; D O Castell; S Cohen; R J Crossley; C E Pope; C S Winans
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

4.  Impaired cimetidine absorption due to antacids and metoclopramide.

Authors:  R Gugler; M Brand; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  4 in total
  6 in total

1.  Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.

Authors:  J P Galmiche; G Brandstätter; M Evreux; E Hentschel; E Kerstan; P Kratochvil; W Reichel; K Schütze; J C Soule; J Vitaux
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

Review 2.  A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.

Authors:  N Sharma; C Donnellan; C Preston; B Delaney; G Duckett; P Moayyedi
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  Combination of cimetidine and alginic acid: an improvement in the treatment of oesophageal reflux disease. Cooperative Oesophageal Group.

Authors: 
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 4.  Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.

Authors:  N J Bell; R H Hunt
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

Review 5.  Pharmacological management of gastro-oesophageal reflux disease.

Authors:  E C Klinkenberg-Knol; H P Festen; S G Meuwissen
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

6.  Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials.

Authors:  Matías E Manzotti; Hugo N Catalano; Fernando A Serrano; Gisela Di Stilio; María F Koch; Gordon Guyatt
Journal:  Open Med       Date:  2007-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.